TENS for Phantom Limb Pain Prevention Following Major Amputation

Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Other)
Overall Status
Unknown status
CT.gov ID
NCT02496351
Collaborator
(none)
40
1
2
22
1.8

Study Details

Study Description

Brief Summary

A growing body of literature indicates that up to 80% of amputees may have phantom limb pain (PLP). The first cause for limb loss is vascular disease. Usually, amputees who suffer from PLP are suboptimal treated. Therefore, many amputees are disabled by their chronic pain. The etiology and pathophysiology of PLP are poorly understood. Some studies suggest a somatosensory cortex reorganization. Transcutaneous Electrical Nerve Stimulation (TENS) is a analgesic technique. TENS apply a low voltage electrical current through the skin using surface electrodes in order to stimulate afferent nerve fibbers. Because of the lack of evidence to support any treatment for PLP, interest has turned to preventing it instead.

The aim of this study is to assess if the early use of TENS in the immediately postoperative of major limb amputation due to peripheral vascular disease, should decrease the PLP incidence. TENS should interfere in the mechanism of PLP production to level of the pain fibers conduction.

Condition or Disease Intervention/Treatment Phase
  • Device: TENS INTERVENTION
N/A

Detailed Description

Introduction:

Postamputation pain is highly prevalent after vascular limb amputation. The physiopathological basis should be divided in supraspinal, spinal and peripheral mechanisms. Supraspinal mechanism involve somatosensory cortical reorganization; spinal reorganization in the dorsal horn, occurs after deafferentation from peripheral nerve injury and peripherical nerve injury begins with the nerve section in surgery. All this factors seems to end into a somatosensory cortex reorganization. In this sense, it seems that our ability to prevent PLP depend on the capability to modulate the plasticity of the Central Nervous System (CNS).

Transcutaneous electrical nerve stimulation it´s a safe, easy and inexpensive analgesic technique acting on the conduction pathways of pain. An adequated program is mandatory: balanced symmetrical biphasic pulse, pulse length greater than 250microsg, modulated high frequency and electrodes placed over the dermatomes corresponding to lumbar-sacral spine; will be used in the intervention patients

Hypothesis:

In patients with TENS use during the immediately postoperative of major limb amputation due to peripheral vascular disease, phantom limb pain will appear with less frequency than in control patients.

Study population:

Patients undergoing major limb amputation for peripheral vascular disease.

Study design:

A randomized, prospective, blinded (patient, physician, statistician),clinical trial placebo versus intervention group study has been design.

In the intervention arm, TENS should be applied during the 24 hours immediately after limb amputation. The placebo arm, also will carry TENS but without an active program.

All patients should receive the standard analgesic treatment for limb amputation during their hospitalization time.

Evaluation and objectives:

Before surgery all patients made two test for pain evaluation: The Analogical Visual Scale and the DN4 questionnaire for neuropathic pain.

At 3 days, 1 month and 3 months after surgery, all patients will be evaluated about their pain using the recommended test for neuropathic pain:The Analogical Visual Scale and the DN4 (neuropathic pain 4) questionnaire for neuropathic pain . Also, at month 1 and 3th, two more test should be done in order to evaluate quality of life: The SF-12 (short form-12) health survey questionnaire about health and the Medical Outcomes Study (MOS) for sleep test.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Transcutaneous Electrical Nerve Stimulation (TENS) for Phantom Limb Pain Prevention Following Arteriopathic Major Amputation: Clinical Trial
Study Start Date :
May 1, 2015
Anticipated Primary Completion Date :
Nov 1, 2016
Anticipated Study Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: TENS INTERVENTION

In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours. The intensity of the impulse will be determined in a test carried out 3 days before surgery. The other parameters will be continuous, biphasic, compensated and symmetric impulse, frequency of 80 Hz, time impulse between 250 and 290 microseconds, modulation time 5´´

Device: TENS INTERVENTION
24 hours of TENS treatment in the immediately postoperative of limb amputation

Placebo Comparator: TENS NO INTERVENTION

In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours, but in this case TENS just will be on. No intensity impulse should be programmed.

Outcome Measures

Primary Outcome Measures

  1. PREOPERATIVE PAIN EVALUATION [3 days before intervention]

    Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10 DN4 Test ( for neurophatic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neurophatic pain.

  2. PREOPERATIVE NEUROPAThIC PAIN EVALUATION [3 days before intervention]

    DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.

Secondary Outcome Measures

  1. INMEDIATELY POSTOPERATIVE PAIN EVALUATION [3 days after intervention]

    Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10

  2. INMEDIATELY POSTOPERATIVE PAIN EVALUATION [3 days after intervention]

    DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.

  3. 1 MONTH POSTOPERATIVE PAIN EVALUATION [1 MONTH]

    Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10

  4. 1 MONTH POSTOPERATIVE PAIN EVALUATION [1 MONTH]

    DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.

  5. 1 MONTH POSTOPERATIVE HEALTH EVALUATION [1 MONTH]

    Test SF-12 about health situation. This is the recommended test of the Spanish Pain society for subjective evaluation of health situations. It consist in 12 questions about its own perceptions, employment status, daily activities, frame of mind

  6. 1 MONTH POSTOPERATIVE SLEEP EVALUATION [1 MONTH]

    Test MOS (Sleep Scale from the Medical Outcomes Study) Some questions for sleep evaluation

  7. 3 MONTH POSTOPERATIVE PAIN EVALUATION [3 MONTH]

    Analogical Visual Scale: the patient indicate its pain level in the scale witch has an interval between 0-10

  8. 3 MONTH POSTOPERATIVE PAIN EVALUATION [3 MONTH]

    DN4 Test ( for neuropathic pain). This is the recommended test of the Spanish association on Anesthesiology for determinate neuropathic pain. It consist in several questions to evaluate the clinical situation and some others about the physical situation.

  9. 3 MONTH POSTOPERATIVE HEALTH EVALUATION [3 MONTH]

    Test SF-12 about health situation. This is the recommended test of the Spanish Pain society for subjective evaluation of health situations. It consist in 12 questions about its own perceptions, employment status, daily activities, frame of mind

  10. 3 MONTH POSTOPERATIVE SLEEP EVALUATION [3 MONTH]

    Test MOS (Sleep Scale from the Medical Outcomes Study) Some questions for sleep evaluation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age over 18 years of both genders

  • Critical limb ischemia (arteriopathic or diabetic aetiology)

  • "MINI MENTAL TEST" (minimum 24 points)

Exclusion Criteria:
  • Pace marker

  • Don´t speak Spanish

  • Not agreement with the study

  • Dermatological lesion affecting the electrode place

Contacts and Locations

Locations

Site City State Country Postal Code
1 hospital General Universitario de Castellon Castellon de la Plana Spain 12004

Sponsors and Collaborators

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Investigators

  • Principal Investigator: Barbara Bodega, Mrs, Hospital General Universitario de Castellon. Avenida Benicassim sn 12004. Castellon. Spain

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Barbara Bodega, MD, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
ClinicalTrials.gov Identifier:
NCT02496351
Other Study ID Numbers:
  • 161976BBM
First Posted:
Jul 14, 2015
Last Update Posted:
Jul 15, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Barbara Bodega, MD, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2015